Đang chuẩn bị liên kết để tải về tài liệu:
The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Rituximab is a B cell depleting anti-CD20 monoclonal antibody. CD20 is not expressed on mature plasma cells and accordingly rituximab does not have immediate effects on immunoglobulin levels. However, after rituximab some patients develop hypogammaglobulinaemia. |